Literature DB >> 4591001

Serum IgG and renal transplantation.

G Ku, Z Varghese, O N Fernando, R Baillod, J P Hopewell, J F Moorhead.   

Abstract

In 57 patients with renal allografts the prolonged administration of prednisolone >/= 1 mg/kg/day and azathioprine >/= 3 mg/kg/day caused a significant and persistent fall in serum IgG at all levels of creatinine clearance. The fall in IgG was more striking when creatinine clearance was below 25 ml/min. At lower doses of azathioprine and prednisolone serum IgG fell when the creatinine clearance was less than 35 ml/min, the degree of recovery towards normal being dependent on creatinine clearance and dosage. Post-transplant haemodialysis decreased the depression of IgG, and patients with immediately functioning grafts had minimal IgG depression. An inverse relation between IgG and IgM was observed in some patients. Severe infections and toxicity were associated with the greatest reduction in IgG; leucopenia and thrombocytopenia were not consistently reliable guides to toxicity. The deaths of four patients (7%) were associated with severe infections. Falls in IgG were not related to the rejection process. IgG measurement should be used as a guide to immunosuppression and toxicity in renal allograft patients.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4591001      PMCID: PMC1587902          DOI: 10.1136/bmj.4.5894.702

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Infectious risk factors in the immunosuppressed host.

Authors:  R J Anderson; L A Schafer; D B Olin; T C Eickhoff
Journal:  Am J Med       Date:  1973-04       Impact factor: 4.965

2.  Immunosuppressive therapy. The relation between clinical response and immunologic competence.

Authors:  M A Swanson; R S Schwartz
Journal:  N Engl J Med       Date:  1967-07-27       Impact factor: 91.245

3.  Death after transplantation; an analysis of sixty cases.

Authors:  R B Hill; B E Dahrling; T E Starzl; D Rifkind
Journal:  Am J Med       Date:  1967-03       Impact factor: 4.965

4.  Reliability of the changes of serum complement, C3, and immunoglobulins during acute rejection of renal allografts: correlations with clinical severity.

Authors:  B Rodriguez-Iturbe; H Serrano; R García; B Gallegos
Journal:  Transplantation       Date:  1971-11       Impact factor: 4.939

5.  Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970.

Authors:  H Festenstein; R T Oliver; J A Sachs; J M Burke; E Adams; W Divver; A Hyams; G D Pegrum; I C Balfour; J F Moorhead
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

6.  Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone.

Authors:  I R Mackay
Journal:  Q J Med       Date:  1968-07

7.  Metabolism of autologous 131-I-labelled IgG in patients after renal homo-transplantation.

Authors:  J V Wells; D Jeremy
Journal:  Clin Sci       Date:  1971-05       Impact factor: 6.124

8.  Changes in serum immunoglobulin and complement levels following renal homotransplantation.

Authors:  P H Levine; D A Merrill; P F Kohler; H N Claman
Journal:  Transplantation       Date:  1970-08       Impact factor: 4.939

9.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

10.  The immunoglobulin sequence. I. Arrest by 6-mercaptopurine and restitution by antibody, antigen or splenectomy.

Authors:  K Sahiar; R S Schwartz
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

View more
  2 in total

1.  Infection in the renal transplant patient.

Authors:  P R Walker; J F Moorhead
Journal:  J R Soc Med       Date:  1978-02       Impact factor: 18.000

Review 2.  Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations.

Authors:  Hans-Hartmut Peter; Hans D Ochs; Charlotte Cunningham-Rundles; Donald C Vinh; Peter Kiessling; Bernhard Greve; Stephen Jolles
Journal:  J Allergy Clin Immunol       Date:  2020-09       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.